Skip to main content
UniHealth

Doctor search

Vivek Bhalla, MD

Nephrology · Stanford

NPI 1730118738

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
13
2 carriers
Offices
2

Offices

2 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

13 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bhalla’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

13 of 13 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A70125 · Current

Licensed to practise in California · since 1999 · expires 2027-09-30 · University of California, San Diego School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$26,230

Medicare paid this office $26,230 for 166 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes57$8,000$67
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes41$2,831$41
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes18$2,639$106
Hemodialysis procedure with physician evaluation26$2,273$61
Return visit (30+ min)17$1,522$85
See all 8 services
Every Original Medicare service billed
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes57$8,000$67
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes41$2,831$41
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes18$2,639$106
Hemodialysis procedure with physician evaluation26$2,273$61
Return visit (30+ min)17$1,522$85
Return visit (30+ min)13$1,498$115
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes18$1,266$67
Short return visit (20+ min)14$1,055$70

Who their Medicare patients are

166 Original Medicare patients in 2024. Average age 70 · Under 65 26% · 85 and older 11% · Women 50% · Also on Medicaid 43% · Health risk score 5.44. Above the middle of the specialty; the typical nephrology clinician is at 4.01.

Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 57% · Heart failure 51% · Coronary heart disease 50% · Atrial fibrillation 41% · Depression 25% · Dementia 23% · Cancer 19% · Stroke 19% · COPD 17%.

The office billed $125,525, Medicare allowed $34,498 and paid $26,230; for 362 services of 15 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024166362705.44$125,525$26,230
2023232509724.97$170,241$36,623
2022229621724.21$208,521$42,280
2021194510703.77$198,325$37,423
2020149413694.24$141,926$27,700
2019181463693.93$137,669$34,655
2018171448694.64$110,028$30,014
2017188518674.88$132,155$32,108
2016157469664.58$105,993$26,829
2015166528654.76$130,960$30,396
2014134379654.67$87,715$20,792
201389195664.59$45,918$11,321

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 11 services

Original Medicare services billed in 2023
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes60$8,609$73
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes80$5,715$44
Return visit (30+ min)33$3,785$90
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes18$2,962$110
Long return visit (40+ min)19$2,926$133
Short return visit (20+ min)37$2,799$58
New patient visit (60+ min)15$2,505$167
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes31$2,268$73
Hemodialysis procedure with physician evaluation17$1,969$66
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes12$1,435$120
Short return visit17$588$31

2022: 10 services

Original Medicare services billed in 2022
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes81$8,811$65
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes25$5,144$94
Hemodialysis procedure with physician evaluation37$4,725$67
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes61$4,455$35
Short return visit (20+ min)50$3,941$58
Return visit (30+ min)37$3,890$90
Long return visit (40+ min)25$3,698$123
New patient visit (60+ min)16$2,361$148
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes26$2,350$90
Short return visit21$711$30

2021: 11 services

Original Medicare services billed in 2021
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes49$6,373$66
Return visit (30+ min)39$4,807$92
Short return visit (20+ min)51$4,321$60
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes15$3,723$95
Hemodialysis procedure with physician evaluation28$3,712$67
Long return visit (40+ min)23$3,360$129
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes35$3,225$92
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes42$2,796$35
New patient visit (60+ min)16$2,232$140
New patient visit (45+ min)15$1,896$126
Short return visit17$640$32

2020: 8 services

Original Medicare services billed in 2020
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes54$8,276$66
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes18$3,713$98
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes42$3,045$35
Hemodialysis procedure with physician evaluation26$2,949$69
Return visit (30+ min)35$2,734$70
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes22$2,163$94
New patient visit (60+ min)11$1,571$143
Short return visit (20+ min)19$791$38

2019: 8 services

Original Medicare services billed in 2019
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes69$9,241$66
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes28$7,452$94
Return visit (30+ min)45$4,163$71
Hemodialysis procedure with physician evaluation25$3,319$66
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes34$3,180$91
New patient visit (60+ min)14$2,132$152
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes27$1,350$36
Short return visit (20+ min)19$929$46

2018: 8 services

Original Medicare services billed in 2018
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes66$9,871$65
Return visit (30+ min)47$5,934$71
Hemodialysis procedure with physician evaluation37$3,182$65
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes23$2,066$90
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes34$1,958$35
New patient visit (60+ min)13$1,957$151
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes16$1,872$94
Short return visit (20+ min)25$1,336$46

2017: 8 services

Original Medicare services billed in 2017
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes94$13,373$65
Return visit (30+ min)37$3,858$70
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes48$2,969$35
Hemodialysis procedure with physician evaluation29$2,575$64
Short return visit (20+ min)42$2,419$43
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes14$1,870$93
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes20$1,794$90
New patient visit (45+ min)11$1,271$116

2016: 7 services

Original Medicare services billed in 2016
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes53$8,521$64
Short return visit (20+ min)54$4,420$45
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes48$3,000$34
Return visit (30+ min)32$2,942$70
Hemodialysis procedure with physician evaluation25$2,457$65
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes20$1,784$89
New patient visit (45+ min)14$1,553$111

2015: 7 services

Original Medicare services billed in 2015
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes85$11,346$64
Return visit (30+ min)37$4,400$67
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes54$3,926$34
Hemodialysis procedure with physician evaluation35$3,509$64
Short return visit (20+ min)29$2,117$43
Dialysis procedure including 1 evaluation11$1,772$77
New patient visit (30+ min)11$739$67

2014: 6 services

Original Medicare services billed in 2014
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes62$8,070$64
Short return visit (20+ min)34$3,056$42
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes43$2,845$35
Hemodialysis procedure with physician evaluation31$2,388$65
Return visit (30+ min)14$1,398$70
New patient visit (30+ min)13$878$68

2013: 6 services

Original Medicare services billed in 2013
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes30$3,662$62
Short return visit (20+ min)26$2,200$42
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes12$1,656$118
Hemodialysis procedure with physician evaluation16$1,250$63
New patient visit (30+ min)14$845$60
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes13$772$34

Medicaid work

$2,497 in 2024

Medicaid paid $2,497 for 119 billed services this clinician did in 2024, up to 20 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES92$2,158
Hemodialysis procedure with single evaluation by a physician or other qualified health care professional27$338
Medicaid work by year
2024119220$2,497
202353216$1,035
2022136218$3,454
2021104217$2,966
202072214$2,062
201934118$1,106
201835113$1,233
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES29$599
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES24$436

2022

Largest Medicaid services in 2022
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES72$2,004
SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES64$1,450

2021

Largest Medicaid services in 2021
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES68$1,983
SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES36$983

2020

Largest Medicaid services in 2020
SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES47$1,105
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES25$958

2019

Largest Medicaid services in 2019
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES34$1,106

2018

Largest Medicaid services in 2018
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES35$1,233

Drugs they prescribed that Part D paid

$64,036

Pharmacies billed $64,036 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 407) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.

368 generic and 39 brand-name prescriptions · $64,036 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Farxiga19$22,963$1,209
Eplerenone37$7,680$208
Guanfacine22$676$31
Chlorthalidone33$533$16
Spironolactone50$436$9
See all 10 drugs
Every Part D drug this clinician prescribed
Farxiga19$22,963$1,209
Eplerenone37$7,680$208
Guanfacine22$676$31
Chlorthalidone33$533$16
Spironolactone50$436$9
Losartan24$401$17
Furosemide25$340$14
Amlodipine Besylate29$125$4
Lisinopril12$105$9
Allopurinol12$98$8

Year by year

Part D prescribing by year
2024407890% (0)10%$64,036
20235801030% (0)9%$81,675
20226761100% (0)16%$112,908
20215711080% (0)14%$83,010
2020341630% (0)15%$48,264
201954380NoneNone$67,536
2018431730% (0)16%$45,899
2017381560% (0)None$23,964
2016338530% (0)22%$17,257
201528748NoneNone$13,496
201420137None21%$5,343
2013129300% (0)21%$6,880

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 16 drugs

Part D drugs prescribed in 2023
Farxiga22$34,277$1,558
Eplerenone69$11,767$171
Chlorthalidone79$1,651$21
Nebivolol11$949$86
Spironolactone51$719$14
Amlodipine Besylate43$527$12
Lisinopril18$401$22
Losartan34$399$12
Potassium Chloride15$372$25
Guanfacine15$358$24
Furosemide22$317$14
Atorvastatin20$296$15
Clonidine17$289$17
Allopurinol13$256$20
Carvedilol13$219$17
Doxazosin Mesylate11$149$14

2022: 14 drugs

Part D drugs prescribed in 2022
Farxiga44$38,063$865
Eplerenone57$16,266$285
Chlorthalidone104$2,134$21
Spironolactone56$1,103$20
Olmesartan Medoxomil12$603$50
Losartan33$436$13
Doxazosin Mesylate14$361$26
Amlodipine Besylate36$277$8
Carvedilol19$275$14
Atorvastatin23$270$12
Allopurinol12$247$21
Furosemide23$246$11
Lisinopril20$235$12
Clonidine21$167$8

2021: 14 drugs

Part D drugs prescribed in 2021
Eplerenone53$11,629$219
Veltassa11$10,643$968
Bystolic15$5,394$360
Chlorthalidone84$2,012$24
Spironolactone49$731$15
Olmesartan Medoxomil13$602$46
Losartan26$572$22
Doxazosin Mesylate22$565$26
Potassium Chloride15$414$28
Amiloride13$388$30
Amlodipine Besylate39$201$5
Carvedilol13$184$14
Clonidine13$82$6
Lisinopril13$45$3

2020: 7 drugs

Part D drugs prescribed in 2020
Eplerenone29$5,966$206
Chlorthalidone58$1,479$25
Spironolactone41$424$10
Losartan16$340$21
Olmesartan Medoxomil12$114$10
Lisinopril18$76$4
Amlodipine Besylate28$56$2

2019: 14 drugs

Part D drugs prescribed in 2019
Eplerenone40$14,759$369
Chlorthalidone99$2,554$26
Clonidine16$2,210$138
Amiloride17$874$51
Terazosin11$721$66
Olmesartan Medoxomil17$682$40
Doxazosin Mesylate13$601$46
Spironolactone43$576$13
Amlodipine-Olmesartan12$484$40
Furosemide40$348$9
Lisinopril37$283$8
Losartan30$222$7
Amlodipine Besylate14$175$12
Metoprolol11$107$10

2018: 14 drugs

Part D drugs prescribed in 2018
Eplerenone37$14,855$401
Eliquis14$6,106$436
Clonidine13$2,029$156
Chlorthalidone59$1,526$26
Amiloride17$662$39
Spironolactone39$594$15
Olmesartan Medoxomil14$445$32
Calcitriol22$343$16
Allopurinol15$164$11
Furosemide30$163$5
Lisinopril23$162$7
Metoprolol15$129$9
Losartan13$126$10
Amlodipine Besylate11$102$9

2017: 12 drugs

Part D drugs prescribed in 2017
Uloric16$6,007$375
Eplerenone17$4,504$265
Potassium Citrate Er12$1,607$134
Chlorthalidone54$1,154$21
Valsartan16$622$39
Amiloride15$461$31
Mycophenolate Mofetil11$438$40
Spironolactone17$326$19
Furosemide35$293$8
Lisinopril33$184$6
Losartan17$128$8
Amlodipine Besylate14$111$8

2016: 9 drugs

Part D drugs prescribed in 2016
Uloric12$3,988$332
Potassium Citrate Er17$1,525$90
Chlorthalidone50$1,244$25
Potassium Chloride14$523$37
Spironolactone28$391$14
Furosemide46$243$5
Losartan25$203$8
Clonidine11$200$18
Lisinopril22$163$7

2015: 6 drugs

Part D drugs prescribed in 2015
Potassium Chloride13$395$30
Furosemide58$295$5
Lisinopril29$169$6
Fosinopril11$144$13
Losartan16$128$8
Amlodipine Besylate14$65$5

2014: 4 drugs

Part D drugs prescribed in 2014
Clonidine15$238$16
Furosemide34$201$6
Fosinopril12$164$14
Amlodipine Besylate15$132$9

2013: 3 drugs

Part D drugs prescribed in 2013
Diovan11$1,312$119
Fosinopril12$186$16
Furosemide16$58$4

Money from drug and device companies

$22,091 in 2025

Industry payments by year
2025341$17,530$22,091
2024336$20,945$23,703
2023316$14,189$18,165
202224$8,103$8,109
202133$517$779
202011$810$810
201918$2,450$3,916

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
MedtronicSymplicity G3$10,769
27 payments
  • Meals for Symplicity G3 · 2025-11-06 · $95
  • Meals for Symplicity G3 · 2025-10-23 · $43
  • Consulting for Symplicity G3 · 2025-10-01 · $7,916
  • Travel for Symplicity G3 · 2025-09-03 · $44
  • Travel for Symplicity G3 · 2025-08-28 · $30
  • Travel for Symplicity G3 · 2025-08-27 · $139
  • Meals for Symplicity G3 · 2025-08-27 · $10
  • Meals for Symplicity G3 · 2025-08-27 · $57
  • Meals for Symplicity G3 · 2025-08-27 · $27
  • Meals for Symplicity G3 · 2025-08-27 · $16
  • Meals for Symplicity G3 · 2025-08-27 · $51
  • Travel for Symplicity G3 · 2025-08-26 · $28
  • Travel for Symplicity G3 · 2025-08-26 · $179
  • Travel for Symplicity G3 · 2025-08-26 · $29
  • Meals for Symplicity G3 · 2025-08-26 · $54
  • Meals for Symplicity G3 · 2025-08-26 · $22
  • Meals for Symplicity G3 · 2025-08-26 · $32
  • Meals for Symplicity G3 · 2025-08-26 · $68
  • Meals for Symplicity G3 · 2025-08-26 · $32
  • Meals for Symplicity G3 · 2025-08-26 · $181
  • Travel for Symplicity G3 · 2025-08-25 · $179
  • Travel for Symplicity G3 · 2025-08-25 · $29
  • Travel for Symplicity G3 · 2025-07-10 · $619
  • Travel for Symplicity G3 · 2025-07-10 · $5
  • Consulting for Symplicity G3 · 2025-05-16 · $425
  • Consulting for Symplicity G3 · 2025-05-07 · $425
  • Meals for Symplicity G3 · 2025-04-22 · $37
Idorsia Pharmaceuticals USTryvio$5,766
6 payments
  • Meals for Tryvio · 2025-11-06 · $98
  • Meals for Tryvio · 2025-08-08 · $27
  • Meals for Tryvio · 2025-07-22 · $95
  • Travel for Tryvio · 2025-06-19 · $653
  • Consulting for Tryvio · 2025-06-19 · $4,865
  • Meals for Tryvio · 2025-03-31 · $27
AstraZeneca Pharmaceuticals LPNone$5,557
8 payments
  • Consulting · 2025-12-06 · $800
  • Consulting · 2025-12-04 · $400
  • Consulting · 2025-10-01 · $1,200
  • Travel · 2025-04-21 · $460
  • Travel · 2025-04-21 · $796
  • Consulting · 2025-04-21 · $1,499
  • Meals · 2025-04-21 · $138
  • Travel · 2025-04-21 · $263
See all 41 published payments
Every published payment
AstraZeneca Pharmaceuticals LPConsulting · 2025-12-06None$800
AstraZeneca Pharmaceuticals LPConsulting · 2025-12-04None$400
MedtronicMeals · 2025-11-06Symplicity G3$95
Idorsia Pharmaceuticals USMeals · 2025-11-06Tryvio$98
MedtronicMeals · 2025-10-23Symplicity G3$43
AstraZeneca Pharmaceuticals LPConsulting · 2025-10-01None$1,200
MedtronicConsulting · 2025-10-01Symplicity G3$7,916
MedtronicTravel · 2025-09-03Symplicity G3$44
MedtronicTravel · 2025-08-28Symplicity G3$30
MedtronicTravel · 2025-08-27Symplicity G3$139
MedtronicMeals · 2025-08-27Symplicity G3$10
MedtronicMeals · 2025-08-27Symplicity G3$57
MedtronicMeals · 2025-08-27Symplicity G3$27
MedtronicMeals · 2025-08-27Symplicity G3$16
MedtronicMeals · 2025-08-27Symplicity G3$51
MedtronicTravel · 2025-08-26Symplicity G3$28
MedtronicTravel · 2025-08-26Symplicity G3$179
MedtronicTravel · 2025-08-26Symplicity G3$29
MedtronicMeals · 2025-08-26Symplicity G3$54
MedtronicMeals · 2025-08-26Symplicity G3$22
MedtronicMeals · 2025-08-26Symplicity G3$32
MedtronicMeals · 2025-08-26Symplicity G3$68
MedtronicMeals · 2025-08-26Symplicity G3$32
MedtronicMeals · 2025-08-26Symplicity G3$181
MedtronicTravel · 2025-08-25Symplicity G3$179
MedtronicTravel · 2025-08-25Symplicity G3$29
Idorsia Pharmaceuticals USMeals · 2025-08-08Tryvio$27
Idorsia Pharmaceuticals USMeals · 2025-07-22Tryvio$95
MedtronicTravel · 2025-07-10Symplicity G3$619
MedtronicTravel · 2025-07-10Symplicity G3$5
Idorsia Pharmaceuticals USTravel · 2025-06-19Tryvio$653
Idorsia Pharmaceuticals USConsulting · 2025-06-19Tryvio$4,865
MedtronicConsulting · 2025-05-16Symplicity G3$425
MedtronicConsulting · 2025-05-07Symplicity G3$425
MedtronicMeals · 2025-04-22Symplicity G3$37
AstraZeneca Pharmaceuticals LPTravel · 2025-04-21None$460
AstraZeneca Pharmaceuticals LPTravel · 2025-04-21None$796
AstraZeneca Pharmaceuticals LPConsulting · 2025-04-21None$1,499
AstraZeneca Pharmaceuticals LPMeals · 2025-04-21None$138
AstraZeneca Pharmaceuticals LPTravel · 2025-04-21None$263
Idorsia Pharmaceuticals USMeals · 2025-03-31Tryvio$27
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $23,703

Payments by company in 2024
MedtronicSymplicity G3$12,162
23 payments
  • Consulting · 2024-12-16 · $850
  • Meals for Symplicity G3 · 2024-09-26 · $129
  • Consulting · 2024-08-28 · $9,350
  • Travel for Symplicity G3 · 2024-07-18 · $59
  • Travel · 2024-07-17 · $131
  • Meals · 2024-07-17 · $42
  • Meals for Symplicity G3 · 2024-07-17 · $47
  • Meals for Symplicity G3 · 2024-07-17 · $42
  • Meals for Symplicity G3 · 2024-07-17 · $12
  • Meals for Symplicity G3 · 2024-07-17 · $54
  • Meals for Symplicity G3 · 2024-07-16 · $186
  • Travel for Symplicity G3 · 2024-07-16 · $189
  • Travel for Symplicity G3 · 2024-07-16 · $28
  • Meals for Symplicity G3 · 2024-07-16 · $46
  • Meals for Symplicity G3 · 2024-07-16 · $35
  • Meals for Symplicity G3 · 2024-07-16 · $23
  • Meals for Symplicity G3 · 2024-07-16 · $79
  • Meals for Symplicity G3 · 2024-07-16 · $3
  • Meals for Symplicity G3 · 2024-07-16 · $25
  • Travel for Symplicity G3 · 2024-07-15 · $189
  • Travel for Symplicity G3 · 2024-07-15 · $28
  • Travel for Symplicity G3 · 2024-06-21 · $580
  • Travel for Symplicity G3 · 2024-06-21 · $34
Idorsia Pharmaceuticals USTryvio$6,892
7 payments
  • Travel for Tryvio · 2024-10-07 · $490
  • Meals for Tryvio · 2024-10-07 · $6
  • Meals for Tryvio · 2024-10-07 · $14
  • Travel for Tryvio · 2024-10-07 · $25
  • Paid to speak or teach for Tryvio · 2024-10-02 · $3,525
  • Meals for Tryvio · 2024-09-24 · $12
  • Paid to speak or teach for Tryvio · 2024-07-01 · $2,820
AstraZeneca Pharmaceuticals LPNone$4,649
6 payments
  • Consulting · 2024-12-10 · $1,200
  • Consulting · 2024-11-26 · $1,200
  • Consulting · 2024-11-23 · $1,200
  • Consulting · 2024-10-18 · $800
  • Meals · 2024-09-05 · $93
  • Travel · 2024-06-05 · $156

2023: $18,165

Payments by company in 2023
Idorsia Pharmaceuticals USAprocitentan$10,277
8 payments
  • Consulting for Aprocitentan · 2023-12-13 · $7,403
  • Meals for Aprocitentan · 2023-11-10 · $45
  • Travel for Aprocitentan · 2023-11-10 · $2,338
  • Travel for Aprocitentan · 2023-11-10 · $338
  • Meals for Aprocitentan · 2023-11-10 · $25
  • Meals for Aprocitentan · 2023-11-10 · $25
  • Meals for Aprocitentan · 2023-11-10 · $52
  • Meals for Aprocitentan · 2023-11-10 · $50
Bayer Healthcare PharmaceuticalsKerendia$6,876
7 payments
  • Meals for Kerendia · 2023-08-05 · $33
  • Meals for Kerendia · 2023-08-05 · $40
  • Meals for Kerendia · 2023-08-05 · $79
  • Meals for Kerendia · 2023-08-05 · $92
  • Travel for Kerendia · 2023-08-05 · $537
  • Consulting for Kerendia · 2023-08-05 · $5,775
  • Travel for Kerendia · 2023-08-04 · $319
AstraZeneca UKNone$1,011
1 payment
  • Consulting · 2023-08-21 · $1,011

2022: $8,109

Payments by company in 2022
Janssen Scientific AffairsXarelto$4,506
2 payments
  • Consulting · 2022-12-22 · $4,500
  • Meals for Xarelto · 2022-09-08 · $6
Johnson & Johnson Health Care SystemsNone$3,603
2 payments
  • Consulting · 2022-11-22 · $2,340
  • Consulting · 2022-05-04 · $1,263

2021: $779

Payments by company in 2021
MedtronicNone$517
1 payment
  • Consulting · 2021-10-08 · $517
Bayer HealthCare PharmaceuticalsKerendia$137
1 payment
  • Meals for Kerendia · 2021-09-14 · $137
Ablative SolutionsNone$125
1 payment
  • Meals · 2021-07-27 · $125

2020: $810

Payments by company in 2020
Bayer HealthCare PharmaceuticalsNon-Covered$810
1 payment
  • Paid to speak or teach for Non-Covered · 2020-02-14 · $810

2019: $3,916

Payments by company in 2019
RelypsaVeltassa$3,916
8 payments
  • Consulting for Veltassa · 2019-07-19 · $2,450
  • Travel for Veltassa · 2019-07-19 · $130
  • Travel for Veltassa · 2019-07-12 · $25
  • Meals for Veltassa · 2019-07-12 · $214
  • Travel for Veltassa · 2019-07-11 · $563
  • Travel for Veltassa · 2019-07-11 · $311
  • Travel for Veltassa · 2019-07-11 · $99
  • Meals for Veltassa · 2019-07-11 · $125

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
AstraZeneca Pharmaceuticals LP · A Randomised,Double Blind,Placebo Controlled,Parallel Group Study To Assess the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two Or More Medications Including Participants With Resistant Hypertension · 2025Their institution$48,544
AstraZeneca Pharmaceuticals LP · A Randomised,Double Blind,Placebo Controlled,Parallel Group Study To Assess the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two Or More Medications Including Participants With Resistant Hypertension · 2024Their institution$44,167

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1730118738
Licence
CA A70125California A70125: Current · expires 2027-09-30
Trained
University of California, San Diego School of Medicine, 1998
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Medicaid ID
CA 00A701250
Taxonomy
Federal specialty code 207RN0300X (207RN0300X); Internal medicine (207R00000X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2006-07-02
NPI last updated
2024-04-17
NPI record certified
2024-04-17

This is when the NPI record was last certified, not a medical board exam.